Control of vascular and renal risk factors in diabetic patients - Results of the Barbanza Diabetes Educational Programme

European Journal of General Practice

Volumn 10, Issue 3, 2004, Pages 109-110

  González Juanatey, José Ramón ^a   Mazón Ramos, Ma Pilar ^a   Allut Vidal, German ^b   Pérez Llamas, Miguel ^b   Blanco Rodriguez, Rubén ^b   Pastor Benavent, Ma Carmen ^b   Alvear García, Martín Jorge ^b   Fernández Seoane, Antonio ^b   Besada Gesto, José Ricardo ^c   Santos Rodrigues, José Antonio ^c   Lado Llerena, Ángel ^c   Eiris Cambre, Ma Jesús ^c   Ramos González, Ana ^c   Gutiérrez Fernández, Genaro ^c   Maestro Saavedra, Javier ^c   De La Fuente Marinño, Rosa ^c   Vaamonde Mosquera, Leopoldo ^c   Gómez Vázquez, José Luis ^c   De Blas Abad, Paula ^c   Villaverde, Ma Fernández ^c   Domínguez López, Jerónimo ^c   Lado López, Manuel ^c   Caneda Villar, Carmen ^c   Dopico Pita, Jaime ^c   Sánchez Loureiro, Manuel ^c   Nores Lorenzo, Augusto ^c   Parga García, Vicente ^c   Rodriguez Moldes, Esperanza ^c   Juiz Crespo, Adoración ^c   Zugaza Gurruchaga, Lucrecia ^c   Turrado Turrado, Victorino ^c   De Frutos Marcos, Concepción ^c   Torres Colomer, Jorge ^c   Feijoo Juarrros, Natividad ^c   more..

^a University Hospital of Santiago de Compostela   (Spain)

^b Primary Care Unit   (Spain)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN;

AGED; ARTICLE; CLINICAL PRACTICE; DATA ANALYSIS; DIABETES MELLITUS; EDUCATION PROGRAM; FEMALE; GENERAL PRACTITIONER; HUMAN; KIDNEY DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SAMPLE SIZE; SPAIN; VASCULAR DISEASE; VOLUNTEER;

EID: 5044229142     PISSN: 13814788     EISSN: None     Source Type: Journal    
DOI: 10.3109/13814780409044548     Document Type: Article

References (9)

1. American Diabetes Association. Clinical Practice Recommendations 2002. Diabetes Care 2002;25(suppl 1):s1-s147.
2. Gaede P, Vedel P, Larsen N, Jensen GVH, Parking HH, Pedersen O. Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes. N Engl J Med 2003;348:383-93.
3. González-Juanatey JR. Blood pressure control in patients with type 2 diabetes and hypertension. Diabetes Obes Metab 2002;4:81-8.
4. González-Juanatey JR, Alegría E, García Acuña JM, González Maqueda I, Vicente Lozano J. Impacto de la diabetes en las enfermedades cardíacas en España. Estudio CARDIOTENS 1999. Med Clin (Barc) 2001;116:686-691.
5. García Vallejo O, Vicente Lozano J, Vegazo O, Jimenez Jimenez FJ, Llisterri JL, Redón J, en representación de los investigadores del estudio DIAPA. Control de la presión arterial de los pacientes diabéticos en el ámbito de atenció n primaria. Estudio DIAPA. Med Clin (Barc) 2003;120:529-34.
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 2003;289:2560-72.
7. Vijan S, Hayward RA. Treatment of hypertension in Type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care. Ann Intern Med 2003;138:593-602.
8. Zanchetti A, Cifkova R, Fagard S, Kjeldsen S, Mancia G, Poulter N, et al., (writing committee). 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:10011-53.
9. González-Juanatey JR, Mazón P, Soria F, Barrios V, Rodríguez-Padial L, Bertomeu V. Actualización (2003) de las Guías de Práctica Clínica de la Sociedad Españ ola de Cardiología en hipertensión arterial. Rev Esp Cardiol 2003;56:487-97.